7113 (Docusate Sodium 250 mg)
Pill with imprint 7113 is Red, Capsule-shape and has been identified as Docusate Sodium 250 mg. It is supplied by Watson Pharmaceuticals.
Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 7113
Docusate Sodium
- Imprint
- 7113
- Strength
- 250 mg
- Color
- Red
- Size
- 20.00 mm
- Shape
- Capsule-shape
- Availability
- Rx and/or OTC
- Drug Class
- Laxatives
- Pregnancy Category
- N - Not classified
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00536-3757 (Discontinued)
- Inactive Ingredients
-
FD&C Red No. 40,
FD&C Yellow No. 6,
gelatin,
glycerin,
polyethylene glycol,
propylene glycol,
water,
sorbitol
Note: Inactive ingredients may vary.
Related Images for "7113"
More about docusate
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (33)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: laxatives
Patient resources
- Other brands
- Colace, DOK, Dulcolax Stool Softener, Surfak, ... +4 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.